ERBB2 and breast cancer: Moreover, since members of EGFR family, including HER1, HER2, HER3, or HER4, are known to stimulate the MEK-ERK pathway [135,136], it can plausibly be involved in the enhanced expression of miR-21 in breast cancer cells.